Scarica l'app Stockscreener
1.10
0.90%
-0.01
Dopo l'orario di chiusura:
1.07
-0.03
-2.73%
Nuwellis Inc Borsa (NUWE) Ultime notizie
Investment Report: Does Nuwellis Inc have pricing power2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn
Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan
Nuwellis completes acquisition of Rendiatech for renal monitoring By Investing.com - Investing.com South Africa
CEO Moves: How correlated is VIVK to the S P5002026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com
Nuwellis completes acquisition of Rendiatech for renal monitoring - Investing.com
Nuwellis completes acquisition of Rendiatech, expanding technology portfolio - Investing.com
Nuwellis, Inc. Completes Acquisition of Rendiatech, Expanding Automated Kidney Monitoring Technology Portfolio - Minichart
Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - GuruFocus
Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - TipRanks
Nuwellis Completes Acquisition of Rendiatech - Bitget
Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan
Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan
Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript - MSN
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - AOL.com
Nuwellis, Inc. 2026 Annual Report: Aquadex System Market, Risks, and Regulatory Overview - Minichart
Nuwellis Q4 Earnings Call Highlights - Defense World
Nuwellis 10-K: $8.27M Revenue, $(25.39) Loss Per Share - TradingView
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Nuwellis Inc (NUWE) Reports Q4 Earnings - AlphaStreet
Nuwellis Earnings Call: Margin Gains Amid Cash Strain - TipRanks
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth - Investing.com Nigeria
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth By Investing.com - Investing.com South Africa
Nuwellis (NUWE) Q4 2025 revenue rises 4% as yearly loss widens - Stock Titan
Nuwellis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nuwellis (NUWE) Reports Increased Q4 Revenue Amidst Strategic Re - GuruFocus
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results - Bitget
BRIEF-Nuwellis Q4 EPS USD -1.5 - TradingView
Nuwellis Q4 2025 Earnings Call Transcript - MarketBeat
Nuwellis Earnings Preview - Benzinga
Nuwellis Inc expected to post a loss of $1.56 a shareEarnings Preview - TradingView
Nuwellis appoints Stuart Goldstein as clinical strategy director By Investing.com - Investing.com Canada
Nuwellis appoints Stuart Goldstein as clinical strategy director - Investing.com Nigeria
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy - Bitget
NUWEForm PRE 14AOther preliminary proxy statements - ADVFN Ltd
Nuwellis (NUWE) director David McDonald reports nonstatutory option holdings - Stock Titan
NUWE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NUWE Technical Analysis & Stock Price Forecast - Intellectia AI
Nuwellis adds two directors with medical device experience By Investing.com - Investing.com Australia
Nuwellis Expands Board With New Independent Financial Experts - TipRanks
Nuwellis adds two directors with medical device experience - Investing.com
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors - The Manila Times
1.69%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):